Acr response criteria

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

ACR Responder Criteria

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Rheumatological effectiveness parameter of the American College of Rheumatology (ACR20-ACR70) for measuring the success of therapy, which has become generally accepted, especially in clinical studies.

General informationThis section has been translated automatically.

  • The ACR response criteria evaluate whether the therapy has led to an improvement of predefined symptoms. An ACR20 efficiency is present, for example, if the patient has experienced at least 20% improvement of the following parameters compared to the initial value:
    • Number of sensitive/painful joints
    • Number of swollen joints
  • In addition, 3 of the following 5 parameters must show an improvement of > 20% compared to the initial value:
    • physician's global assessment of the arthritic condition
    • Patient's global assessment of the arthritic condition
    • Pain (visual analogue scale (VAS)
    • HAQ functional disability index (HAQ)
    • CRP value (CRP, S-reactive protein).
For modern, effective substances, especially from the group of long-acting antirheumatic drugs, a > 50% improvement is demanded today. The following clinical and laboratory parameters are determined: number of pressure-sensitive and swollen joints as well as 3 out of 5 of the criteria pain, global assessment by patient and examiner, blood sedimentation, C-reactive protein.

LiteratureThis section has been translated automatically.

  1. Felson DT, Anderson JJ (2001) A review of evidence on the discriminant validity of outcome measures in rheumatoid arthritis. J Rheumatol 28: 422-426

Authors

Last updated on: 29.10.2020